700. Safety and Efficacy of Omadacycline in Patients with Diabetes in Phase 3 Clinical Studies

BACKGROUND: The risk of serious infections and poor treatment outcomes is reported to be higher in patients with diabetes compared with the general population. Omadacycline (OMC) is an intravenous (IV) and oral aminomethylcycline antibiotic approved in the US to treat acute bacterial skin and skin s...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Open Forum Infect Dis
Main Authors: Pai, Manjunath P, Wilcox, Mark H, Curran, Marla, Chitra, Surya, Garrity-Ryan, Lynne, McGovern, Paul C
Formato: Artigo
Idioma:Inglês
Publicado em: Oxford University Press 2019
Assuntos:
Abstracts
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6811084/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ofid/ofz360.768
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados